# OnCo record btg2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/btg2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "btg2" ;
  schema:name "BTG2"@en ;
  schema:alternateName "BTG anti-proliferation factor 2"@en, "PC3"@en, "TIS21"@en, "MGC126063"@en, "MGC126064"@en, "APRO1"@en, "BTG2" ;
  schema:description "BTG2 (BTG anti-proliferation factor 2) is a protein that switches other genes on and off. The public catalogues list it as an oncogene driver, a tumour suppressor and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Non-Hodgkin lymphoma, Diffuse large B-cell lymphoma and Chronic lymphocytic leukaemia."@en ;
  schema:url <https://onco.cc/targets/btg2/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1131>, <https://www.uniprot.org/uniprotkb/P78543/entry>, <https://www.ncbi.nlm.nih.gov/gene/7832>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159388> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "transcription" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1131>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159388>, <https://www.uniprot.org/uniprotkb/P78543/entry>, <https://www.ncbi.nlm.nih.gov/gene/7832> ;
  onco:related <https://onco.cc/collections/civic/>, <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/cll/> .